CA1173692A - Compositions d'elements nutritifs et methode pour les administrer - Google Patents

Compositions d'elements nutritifs et methode pour les administrer

Info

Publication number: CA1173692A
Authority: CA; Canada
Prior art keywords: glycine; nutrient composition; oligopeptides; amino acid; oligopeptide
Prior art date: 1980-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000373100A

Other languages

English (en)

Inventor

Siamak A. Adibi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Montefiore Medical Center

Original Assignee

Montefiore Medical Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-03-14

Filing date

1981-03-16

Publication date

1984-09-04

1980-03-14 Priority claimed from US06/130,308 external-priority patent/US4322033A/en

1981-01-26 Priority claimed from US06/227,127 external-priority patent/US4340592A/en

1981-03-16 Application filed by Montefiore Medical Center filed Critical Montefiore Medical Center

1984-09-04 Application granted granted Critical

1984-09-04 Publication of CA1173692A publication Critical patent/CA1173692A/fr

Status Expired legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 21
235000015097 nutrients Nutrition 0.000 title claims description 18
238000000034 method Methods 0.000 title description 4
108010016626 Dipeptides Proteins 0.000 claims abstract description 13
-1 iysine Chemical compound 0.000 claims abstract description 6
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims abstract description 5
125000000539 amino acid group Chemical group 0.000 claims abstract description 4
108010038807 Oligopeptides Proteins 0.000 claims description 34
102000015636 Oligopeptides Human genes 0.000 claims description 34
229920005862 polyol Polymers 0.000 claims description 7
150000003077 polyols Chemical class 0.000 claims description 7
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
239000007864 aqueous solution Substances 0.000 claims description 6
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
239000008103 glucose Substances 0.000 claims description 6
235000020776 essential amino acid Nutrition 0.000 claims description 4
239000003797 essential amino acid Substances 0.000 claims description 4
239000003925 fat Substances 0.000 claims description 3
229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
235000010755 mineral Nutrition 0.000 claims description 3
239000011707 mineral Substances 0.000 claims description 3
239000011573 trace mineral Substances 0.000 claims description 3
235000013619 trace mineral Nutrition 0.000 claims description 3
QGTPORGEFWYTOC-MDTVQASCSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCCCC[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O QGTPORGEFWYTOC-MDTVQASCSA-N 0.000 claims description 2
NYOGGQBMEGUVIX-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-3-methylbutanoic acid Chemical compound NCC(O)=O.CC(C)[C@H](N)C(O)=O NYOGGQBMEGUVIX-WCCKRBBISA-N 0.000 claims description 2
DQSIXGDDUJJEQH-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 DQSIXGDDUJJEQH-QRPNPIFTSA-N 0.000 claims description 2
AYORUWNJMKYNAD-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2-amino-4-methylpentanoic acid Chemical compound NCC(O)=O.CC(C)C[C@H](N)C(O)=O AYORUWNJMKYNAD-JEDNCBNOSA-N 0.000 claims description 2
FZEBFTHYHFLHGE-WFGSYIHQSA-N 2-aminoacetic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound NCC(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O FZEBFTHYHFLHGE-WFGSYIHQSA-N 0.000 claims description 2
MNQVNFIVCSQNGY-FHAQVOQBSA-N 2-aminoacetic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound NCC(O)=O.CC[C@H](C)[C@H](N)C(O)=O MNQVNFIVCSQNGY-FHAQVOQBSA-N 0.000 claims description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
239000008151 electrolyte solution Substances 0.000 claims description 2
229920001542 oligosaccharide Polymers 0.000 claims description 2
150000002482 oligosaccharides Chemical class 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
235000013343 vitamin Nutrition 0.000 claims description 2
239000011782 vitamin Substances 0.000 claims description 2
229940088594 vitamin Drugs 0.000 claims description 2
229930003231 vitamin Natural products 0.000 claims description 2
BKKWZCSSYWYNDS-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCCCC[C@H](N)C(O)=O BKKWZCSSYWYNDS-JEDNCBNOSA-N 0.000 claims 1
DGRZRONVAUBBJY-NAWJVIAPSA-N 2-aminoacetic acid;(2s)-2-amino-3-(1h-indol-3-yl)propanoic acid Chemical compound NCC(O)=O.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 DGRZRONVAUBBJY-NAWJVIAPSA-N 0.000 claims 1
HVBRJSWZFSWZKB-FVGYRXGTSA-N 2-aminoacetic acid;(2s)-2-amino-3-(1h-indol-3-yl)propanoic acid Chemical compound NCC(O)=O.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 HVBRJSWZFSWZKB-FVGYRXGTSA-N 0.000 claims 1
HQEQLJHXFBKKEN-SCGRZTRASA-N 2-aminoacetic acid;(2s)-2-amino-3-methylbutanoic acid Chemical compound NCC(O)=O.CC(C)[C@H](N)C(O)=O.CC(C)[C@H](N)C(O)=O HQEQLJHXFBKKEN-SCGRZTRASA-N 0.000 claims 1
CQBYLZOLQTWVOB-QXGOIDDHSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=CC=C1 CQBYLZOLQTWVOB-QXGOIDDHSA-N 0.000 claims 1
YWEKFRWGKMPCEU-MDTVQASCSA-N 2-aminoacetic acid;(2s)-2-amino-4-methylpentanoic acid Chemical compound NCC(O)=O.CC(C)C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O YWEKFRWGKMPCEU-MDTVQASCSA-N 0.000 claims 1
FSSVRLXFJPQUTM-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O FSSVRLXFJPQUTM-WCCKRBBISA-N 0.000 claims 1
IDFKSUXUURJYNF-SCGRZTRASA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O.CSCC[C@H](N)C(O)=O IDFKSUXUURJYNF-SCGRZTRASA-N 0.000 claims 1
UQFMAFYDEDQTCV-PZXRSRGQSA-N 2-aminoacetic acid;(2s,3r)-2-amino-3-hydroxybutanoic acid Chemical compound NCC(O)=O.C[C@@H](O)[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O UQFMAFYDEDQTCV-PZXRSRGQSA-N 0.000 claims 1
XGKCWNGHLZXLTK-MUWMCQJSSA-N 2-aminoacetic acid;(2s,3r)-2-amino-3-hydroxybutanoic acid Chemical compound NCC(O)=O.C[C@@H](O)[C@H](N)C(O)=O XGKCWNGHLZXLTK-MUWMCQJSSA-N 0.000 claims 1
125000000729 N-terminal amino-acid group Chemical group 0.000 claims 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
230000007717 exclusion Effects 0.000 claims 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
239000000811 xylitol Substances 0.000 claims 1
229960002675 xylitol Drugs 0.000 claims 1
235000010447 xylitol Nutrition 0.000 claims 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 4
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract description 3
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract description 3
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 3
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract description 3
235000004279 alanine Nutrition 0.000 abstract description 3
235000014304 histidine Nutrition 0.000 abstract description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract description 3
229930182817 methionine Natural products 0.000 abstract description 3
239000004474 valine Substances 0.000 abstract description 3
239000004475 Arginine Substances 0.000 abstract description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
235000005911 diet Nutrition 0.000 abstract description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract description 2
235000008729 phenylalanine Nutrition 0.000 abstract description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
235000009697 arginine Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
235000013930 proline Nutrition 0.000 abstract 1
235000001014 amino acid Nutrition 0.000 description 22
229940024606 amino acid Drugs 0.000 description 22
150000001413 amino acids Chemical class 0.000 description 22
150000002500 ions Chemical class 0.000 description 20
239000000243 solution Substances 0.000 description 17
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 14
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
210000004027 cell Anatomy 0.000 description 6
239000004471 Glycine Substances 0.000 description 5
230000032258 transport Effects 0.000 description 5
239000002253 acid Substances 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
210000003462 vein Anatomy 0.000 description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
206010012735 Diarrhoea Diseases 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
235000014105 formulated food Nutrition 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
ZEEYNQNRMIBLMK-DFWYDOINSA-N 2-aminoacetic acid;(2s)-2-aminopentanedioic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CCC(O)=O ZEEYNQNRMIBLMK-DFWYDOINSA-N 0.000 description 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
208000023514 Barrett esophagus Diseases 0.000 description 1
HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
206010020852 Hypertonia Diseases 0.000 description 1
241000188250 Idas Species 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
XDXHAEQXIBQUEZ-UHFFFAOYSA-N Ropinirole hydrochloride Chemical compound Cl.CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2 XDXHAEQXIBQUEZ-UHFFFAOYSA-N 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000000654 additive Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000007882 dietary composition Nutrition 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
239000003814 drug Substances 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000003405 ileum Anatomy 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000001802 infusion Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229960005190 phenylalanine Drugs 0.000 description 1
230000002028 premature Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
235000021476 total parenteral nutrition Nutrition 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA000373100A 1980-03-14 1981-03-16 Compositions d'elements nutritifs et methode pour les administrer Expired CA1173692A (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US06/130,308 US4322033A (en)	1978-07-10	1980-03-14	Lance and method for removing skulls from steelmaking vessels
US130,308		1980-03-14
US06/227,127 US4340592A (en)	1980-03-14	1981-01-26	Nutrient compositions and method of administering the same
US227,127		1981-01-26

Publications (1)

Publication Number	Publication Date
CA1173692A true CA1173692A (fr)	1984-09-04

Family

ID=26828349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000373100A Expired CA1173692A (fr)	1980-03-14	1981-03-16	Compositions d'elements nutritifs et methode pour les administrer

Country Status (1)

Country	Link
CA (1)	CA1173692A (fr)

1981
- 1981-03-16 CA CA000373100A patent/CA1173692A/fr not_active Expired

Publication	Publication Date	Title
US4340592A (en)	1982-07-20	Nutrient compositions and method of administering the same
Vinnars et al.	2003	History of parenteral nutrition
US6060446A (en)	2000-05-09	Method and composition for treating renal disease and failure
US5646118A (en)	1997-07-08	Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
AU682894B2 (en)	1997-10-23	Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
WO1989003688A1 (fr)	1989-05-05	Composition d'amino acide destinee au soutien nutritionnel parenteral et son utilisation
US5189016A (en)	1993-02-23	Nutrient compositions containing peptides and method for administering the same
EP0075594A1 (fr)	1983-04-06	Polymeres de glucose et leur procede de production
Goldberg et al.	1979	Effect of somatostatin on the plasma amino acid response to ingested protein in man
US5122515A (en)	1992-06-16	Nutrient composition containing dipeptides and method for administering the same
CA2134380C (fr)	2010-06-22	Composition a base d'acides amines servant au traitement de la septicemie ou d'une atteinte induisant une reaction inflammatoire
CA1173692A (fr)	1984-09-04	Compositions d'elements nutritifs et methode pour les administrer
JP3182564B2 (ja)	2001-07-03	栄養組成物
JPH07330583A (ja)	1995-12-19	遊離型グルタミン酸を含有する液状製剤
JP3914585B2 (ja)	2007-05-16	マクロファージ一酸化窒素産生亢進剤
JPS61502822A (ja)	1986-12-04	全非経口栄養及び経腸栄養組成物
EP0363337A1 (fr)	1990-04-11	Substrat d'énergie contenant un acide hydroxycarboxylique
JPS5923291B2 (ja)	1984-06-01	アミノ酸および無機塩を含有する注入液
Maksoud et al.	1984	Effect of branched‐chain amino acids and insulin on postinjury protein catabolism in growing animals
JPS6326733B2 (fr)	1988-05-31
JP3429327B2 (ja)	2003-07-22	癌用アミノ酸輸液剤
Naka et al.	1997	Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis
Børresen	1972	Balanced intravenous nutrition in pediatric surgery
JP4187957B2 (ja)	2008-11-26	コリン配合輸液剤
JPH0940554A (ja)	1997-02-10	グルタミンを含む輸液及びその製造方法

Legal Events

Date	Code	Title	Description
2001-09-04	MKEX	Expiry